Virtual nurse support to enhance antipsychotic adherence in schizophrenia: A South African perspective

South African Journal of Psychiatry

 
 
Field Value
 
Title Virtual nurse support to enhance antipsychotic adherence in schizophrenia: A South African perspective
 
Creator Thandar, Yasmeen Mvunelo, Nomhle Singh, Deepak Haffejee, Firoza
 
Subject Psyciatry; Mental Health; Nursing; Public Health; Pharmacotherapy schizophrenia; adherence; antipsychotics; psychiatry; treatment buddy; telemedicine; psychiatric nursing
Description Background: Patients with schizophrenia rely on antipsychotic medication, with adherence being critical for symptom management. Poor adherence leads to relapse, disability and increased healthcare costs.Aim: This study investigated the impact on antipsychotic adherence among schizophrenia patients on the introduction of an intervention utilising a psychiatric nurse as a virtual treatment buddy.Setting: Participants were recruited from a psychiatric clinic in KwaZulu-Natal, South Africa.Methods: This quantitative pre-test-post-test control group study recruited 117 schizophrenia patients. Participants were randomly assigned to an intervention group (n = 82) receiving daily text message support or a control group (n = 35) without support. Pre- and post-intervention questionnaires assessed medication adherence. The McNemar test compared medication cessation frequencies pre- and post-intervention. Pearson’s chi-squared test, factor analysis and linear regressions were employed to correlate variables. A p  0.05 was deemed statistically significant.Results: Adherence improved from 60.8% to 83.51% post-intervention (p  0.001). Obstacles to adherence, including inadequate disease knowledge, treatment duration, side effects, misunderstanding instructions and forgetfulness, were reduced post-intervention. Additionally, symptom relapse, rehospitalisation, specialist referrals, the need for more potent medication and employment loss decreased post-intervention.Conclusion: Virtual buddy support has demonstrated promise in improving medication adherence and minimising adverse effects of discontinuation among schizophrenia patients.Contribution: This study contributes a method to improving antipsychotic adherence and reducing negative outcomes in schizophrenia patients by emphasising personalised support, education and collaborative care among healthcare providers and support systems.
 
Publisher AOSIS
 
Contributor Durban University of Technology
Date 2025-05-31
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — quazi-experimental pre-test-post-test control group design
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajpsychiatry.v31i0.2430
 
Source South African Journal of Psychiatry; Vol 31 (2025); 9 pages 2078-6786 1608-9685
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajp.org.za/index.php/sajp/article/view/2430/3934 https://sajp.org.za/index.php/sajp/article/view/2430/3935 https://sajp.org.za/index.php/sajp/article/view/2430/3936 https://sajp.org.za/index.php/sajp/article/view/2430/3937
 
Coverage South Africa; KwaZulu-Natal June 2021-December 2021 Adults >18 years; male and female; schizophrenia patients
Rights Copyright (c) 2025 Yasmeen Thandar, Nomhle Mvunelo, Deepak Singh, Firoza Haffejee https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT